Compare · DCGO vs PRVA
DCGO vs PRVA
Side-by-side comparison of DocGo Inc. (DCGO) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DCGO and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.70B, about 50.1x DCGO ($53.8M).
- Over the past year, DCGO is down 66.1% and PRVA is down 7.8% - PRVA leads by 58.3 points.
- PRVA has been more active in the news (11 items in the past 4 weeks vs 2 for DCGO).
- PRVA has more recent analyst coverage (25 ratings vs 10 for DCGO).
- Company
- DocGo Inc.
- Privia Health Group Inc.
- Price
- $0.54-2.72%
- $21.42-0.95%
- Market cap
- $53.8M
- $2.70B
- 1M return
- -13.45%
- -10.60%
- 1Y return
- -66.09%
- -7.81%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2021
- News (4w)
- 2
- 11
- Recent ratings
- 10
- 25
DocGo Inc.
DocGo, Inc. provides mobile health services and integrated medical mobility solutions in 26 states in the United States and the United Kingdom. The company's AI-powered transportation and concierge medical services enable its clinical professionals to facilitate patient-centered care, helping improve patient outcomes while reducing the total cost of care for its customers. It also provides medical transport services. As of October 1, 2021, the company had 3,500 medical providers. It serves facilities, hospital networks, and health insurance providers. The company was founded in 2015 and is headquartered in New York, New York.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest DCGO
- DocGo Launches Mobile Phlebotomy Services in South Florida
- DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
- Chief Executive Officer Bienstock Lee covered exercise/tax liability with 15,644 shares, decreasing direct ownership by 0.56% to 2,801,826 units (SEC Form 4)
- SEC Form 10-Q filed by DocGo Inc.
- DocGo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- DocGo Announces First Quarter 2026 Results
- DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
- DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026
- SEC Form DEFA14A filed by DocGo Inc.
- SEC Form DEF 14A filed by DocGo Inc.
Latest PRVA
- Privia Health Enters New Jersey
- Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)
- Director Berberian Lance was granted 8,463 shares, increasing direct ownership by 110% to 16,131 units (SEC Form 4)
- Director Cocozza Nancy G was granted 8,463 shares, increasing direct ownership by 25% to 42,814 units (SEC Form 4)
- Director Kimmet Pamela O was granted 8,463 shares, increasing direct ownership by 33% to 34,172 units (SEC Form 4)
- Director Mccarthy Thomas A was granted 8,463 shares, increasing direct ownership by 43% to 27,983 units (SEC Form 4)
- Director King David P was granted 8,463 shares, increasing direct ownership by 20% to 50,775 units (SEC Form 4)
- Director Ryu Jaewon was granted 8,463 shares, increasing direct ownership by 22% to 47,110 units (SEC Form 4)
- Director Morris Matthew Shawn was granted 8,463 shares, increasing direct ownership by 12% to 76,651 units (SEC Form 4)
- SEC Form 3 filed by new insider Soistman Francis S Jr